- Home
- ALLT vs AURA Comparison
ALLT vs AURA Comparison
Compare ALLT & AURA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ALLT
- AURA
- Stock Information
- Founded
- ALLT 1996
- AURA 2007
- Country
- ALLT Israel
- AURA United States
- Employees
- ALLT N/A
- AURA N/A
- Industry
- ALLT Telecommunications Equipment
- AURA Biotechnology: Pharmaceutical Preparations
- Sector
- ALLT Telecommunications
- AURA Health Care
- Exchange
- ALLT Nasdaq
- AURA Nasdaq
- Market Cap
- ALLT 342.5M
- AURA 396.8M
- IPO Year
- ALLT 2006
- AURA 2021
- Fundamental
- Price
- ALLT $9.27
- AURA $6.18
- Analyst Decision
- ALLT Buy
- AURA Strong Buy
- Analyst Count
- ALLT 1
- AURA 7
- Target Price
- ALLT N/A
- AURA $22.29
- AVG Volume (30 Days)
- ALLT 589.7K
- AURA 156.6K
- Earning Date
- ALLT 08-14-2025
- AURA 11-11-2025
- Dividend Yield
- ALLT N/A
- AURA N/A
- EPS Growth
- ALLT N/A
- AURA N/A
- EPS
- ALLT N/A
- AURA N/A
- Revenue
- ALLT $95,342,000.00
- AURA N/A
- Revenue This Year
- ALLT $10.64
- AURA N/A
- Revenue Next Year
- ALLT $15.76
- AURA N/A
- P/E Ratio
- ALLT N/A
- AURA N/A
- Revenue Growth
- ALLT 4.74
- AURA N/A
- 52 Week Low
- ALLT $2.78
- AURA $4.35
- 52 Week High
- ALLT $10.77
- AURA $12.38
- Technical
- Relative Strength Index (RSI)
- ALLT 67.28
- AURA 40.01
- Support Level
- ALLT $8.53
- AURA $6.20
- Resistance Level
- ALLT $9.58
- AURA $6.61
- Average True Range (ATR)
- ALLT 0.46
- AURA 0.28
- MACD
- ALLT 0.16
- AURA -0.00
- Stochastic Oscillator
- ALLT 84.95
- AURA 1.59
About ALLT Allot Ltd.
Allot Ltd is a provider of network intelligence and security solutions for service providers and enterprises. The company's solutions are deployed globally for network and application analytics, traffic control and shaping, and network-based security services. The firm's multi-service platforms are deployed by mobile, fixed, and cloud service providers and enterprises. The company has a customer base in Europe, Asia and Oceania, the Americas, the Middle East, and Africa.
About AURA Aura Biosciences Inc.
Aura Biosciences Inc is a clinical-stage biotechnology company developing precision immunotherapies to treat a range of solid tumors designed to preserve the function of organs afflicted with cancer. Its candidate bel-sar is in late-stage clinical development for the treatment of patients with primary choroidal melanoma, and other ocular oncology indications as well as in early-stage clinical development in bladder cancer. The Company views its operations and manages its business in one operating segment operating exclusively in the United States.